Publications by authors named "Gary E Fish"

Claim this Profile
P
Patient-Reported Visual Function Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: Preplanned Secondary Analysis of a Randomized Clinical Trial.
Ingrid U Scott, Paul C VanVeldhuisen, Franca Barton, Neal L Oden, Michael S Ip, Gary E Fish

JAMA Ophthalmol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.
David G Birch, Paul S Bernstein, Alessandro Iannacone, Mark E Pennesi, Byron L Lam, Gary Edd Fish

JAMA Ophthalmol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.
Gary Gensler, Traci E Clemons, Amitha Domalpally, Ronald P Danis, Barbara Blodi, Gary E Fish

Ophthalmol Retina· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.
Dennis R Hoffman, Dianna K Hughbanks-Wheaton, Rand Spencer, Gary E Fish, N Shirlene Pearson

Invest Ophthalmol Vis Sci· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.
Dennis R Hoffman, Dianna K Hughbanks-Wheaton, N Shirlene Pearson, Gary E Fish, Rand Spencer

JAMA Ophthalmol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.
Dianna K Hughbanks-Wheaton, David G Birch, Gary E Fish, Rand Spencer, N Shirlene Pearson

Invest Ophthalmol Vis Sci· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

JAMA Ophthalmol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.

JAMA Ophthalmol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular side effects associated with peribulbar injections of triamcinolone acetonide for diabetic macular edema.
Emily Y Chew, Adam R Glassman, Roy W Beck, Neil M Bressler, Gary E Fish

Retina· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreous bevacizumab in the treatment of macular edema from branch retinal vein occlusion and hemisphere retinal vein occlusion (an AOS thesis).
Gary Edd Fish

Trans Am Ophthalmol Soc· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
Dennis R Hoffman, Kirsten G Locke, Dianna H Wheaton, Gary E Fish, Rand Spencer

Am J Ophthalmol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Mohammad Azab, Mustapha Benchaboune, Kevin J Blinder, Neil M Bressler, Susan B Bressler, Gary Edd Fish

Retina· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Neil M Bressler, Jennifer Arnold, Mustapha Benchaboune, Mark S Blumenkranz, Gary E Fish

Arch Ophthalmol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
Mark S Blumenkranz, Neil M Bressler, Susan B Bressler, Guy Donati, Gary Edd Fish

Arch Ophthalmol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration.
David G Birch, Steven M Toler, William H Swanson, Gary E Fish, Alan M Laties

Am J Ophthalmol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis